Skip to content

Cerebrolysin 60mg

♢ Research use only Klassespecifikation; udvalgte partier Janoshik-testet

Indholdsanalyse Content quantification (Janoshik)Cerebrolysin 60mg · Report #212145 ↗

€28.99

Free standard EU shipping on orders over €200

If a product doesn't match the specification on its published COA, contact us with your batch number: we investigate against the lot's report and replace any product that fails it, at no cost to you.

Contact us within 48 hours of delivery with photos of the outer box, inner packing, and any affected vials with labels legible. Confirmed transit damage is replaced at no cost to you.

Returns policy →
Shipping estimate for EU

3–7 days most of the EU · 10–14 Nordics/Baltics. Dispatched within 1–2 business days. Check destination rates at checkout.

Full shipping information

Forskningskvalitet Cerebrolysin. Registreret specifikation: peptidhydrolysat (ekstrakt af svinehjerne), ≥85% peptider ≤10 kDa; udvalgte partier er uafhængigt testet. Lyofiliseret pulver i forseglet hætteglas. Kun til forskningsformål. Ikke beregnet til menneskelig indtagelse.

Om Cerebrolysin 60mg

Cerebrolysin is a multi-peptide brain-derived neurotrophic preparation consisting of enzymatically treated porcine brain protein. The preparation contains a mixture of low-molecular-weight neuropeptides and free amino acids that cross the blood-brain barrier. It has an unusually long history for a peptide complex and has been studied in the context of neurological injury models including ischemic, traumatic, and vascular insults — and has been characterised since the 1970s. Each vial contains 60mg of the lyophilized preparation.

The active components of Cerebrolysin are not fully defined chemically, which distinguishes it from single-compound neurotrophic peptides. The preparation has demonstrated neurotrophic factor-like activity in cell culture and animal models: it promotes neuronal survival, enhances synaptic plasticity, stimulates neurogenesis, and exhibits neuroprotective effects in various injury models. Preclinical and in-vitro studies have examined its effects on recovery and cognitive parameters in injury and neurodegeneration models, with variable results across study designs. The European Medicines Agency has characterised it within some neurological research contexts.

For research purposes, Cerebrolysin is a useful tool for studying multi-factor neurotrophic support — where the combined effect of multiple small peptides may recapitulate some of the biological activity of endogenous neurotrophic factors (BDNF, NGF, GDNF) more completely than any single defined compound.

Specifications

Parameter Value
Compound Cerebrolysin (porcine brain-derived neuropeptide complex)
Amount per Vial 60mg lyophilized
Composition Low-MW neuropeptides + free amino acids from porcine brain proteins
Format Lyophilized powder
Reconstitution Sterile water or saline
Opbevaring 2-8°C

Opbevaring

Store at 2-8°C (refrigerator) as lyophilized powder. Refrigerate after reconstitution. As a biological preparation, avoid freezing and thawing cycles.

What makes Cerebrolysin different from a single neurotrophic peptide?

Single neurotrophic peptides (like BDNF or NGF) target specific receptors. Cerebrolysin contains a mixture of multiple small peptides and amino acids that together mimic aspects of the brain’s complex neurotrophic environment. In research, this can be advantageous when the goal is broad neuroprotection or neurogenesis stimulation rather than receptor-specific pharmacology. The trade-off is that the mixture composition is not fully defined, which limits mechanistic interpretation. Cerebrolysin is better suited for studies where the preparation itself is the research focus, or for generating hypotheses that can then be pursued with defined single compounds.

How does Cerebrolysin penetrate the blood-brain barrier?

Cerebrolysin’s active components are specifically the low-molecular-weight fraction (peptides under approximately 10 kDa) — the preparation is enzymatically processed to ensure these small peptides predominate. Small peptides can cross the blood-brain barrier through passive diffusion (if sufficiently lipophilic), transcytosis, or active transport. The preparation is documented to produce measurable CNS effects after systemic IV or IM administration in preclinical models, indicating at least partial CNS delivery. The full pharmacokinetics of the mixed preparation are complex to characterize precisely.

What are the main research areas for Cerebrolysin?

The most-studied research area for Cerebrolysin is ischemic injury models — preclinical work has examined neurological outcome parameters when administered early in models of ischemic insult. Neurodegeneration models have examined cognitive parameters in some studies but not consistently across designs. Traumatic injury models have been another focus, with preclinical data examining neuroprotection. The research base is heterogeneous in quality, and the compound is characterised differently across regulatory jurisdictions.

Cerebrolysin is supplied for research purposes only. Not for human consumption. Handle in compliance with institutional biosafety guidelines.

Forskertillid

Hvorfor forskere vælger CertaPeptides

Hvem tester det egentlig?

Udvalgte partier verificeres uafhængigt af Janoshik Analytical (Tjekkiet) og offentliggøres på Janoshiks offentlige portal. Andre partier leveres med leverandørens batchspecifikation. Se /coa for den offentliggjorte væg.

Se COA'er →

Hvad hvis jeg får det forkerte parti?

Etiketten på hvert hætteglas bærer en kode. Slå den op på vores verifikationsside: Siden viser, hvad CertaPeptides offentliggør for koden, og for et tilbagetrukket parti, at partiet er trukket tilbage, og hvorfor. Er dit parti trukket tilbage, eller giver koden på din etiket intet resultat, så send os den kode på e-mail.

Se COA'er →

Hvor afsendes det fra?

Rumænien (EU). Vi er CERTALAB SRL, CUI 54169956, momsregistreret. Sameday for Rumænien, GLS til de fleste EU-destinationer, TCE Worldwide for de øvrige grænseoverskridende markeder i og uden for EU (Storbritannien, Schweiz). Levering 1–15 hverdage afhængigt af destination — det præcise interval vises ved kassen.

Forsendelsesdetaljer →

Hvad hvis der er et problem?

Du har 14 dages fortrydelsesret i henhold til OUG 34/2014 (rumænsk/EU-forbrugerlovgivning), med mulighed for eskalering til ANPC og for alternativ tvistbilæggelse (SAL). Kontakt os på support@chinapeptideshop.com.

Returpolitik →

Produktinformation

Dette produkt er udelukkende beregnet til videnskabelig forskning og udvikling. Det er et kemisk stof, der ikke må anvendes som lægemiddel, medicin, aktivt stof eller ingrediens i noget produkt beregnet til konsum hos mennesker eller dyr. Forskere skal håndtere denne forbindelse i overensstemmelse med deres institutions biosikkerhedsretningslinjer. Må kun anvendes i korrekt udstyrede laboratoriemiljøer med passende personlige værnemidler.

Ofte stillede spørgsmål

Forskningsbibliotek

Relaterede forskningsartikler

Se alle

Frequently researched together

Combined Price €157.46

View All Products
Henvis en forsker

Fortæl en forskerkollega om det

Giv 15% rabat, optjen 10% retur på den første ordre, de afgiver.

Cerebrolysin 60mgResearch use only
Added to cart

Essential cookies keep your cart and account working. Optional content is disabled until you allow it.

Recently viewed products stay only in this browser for up to 30 days. Turning optional personalization off clears that history.

europa.eu/youreurope/garantier

Customer support

Live chat is not connected yet. Please contact our support team by email.

support@chinapeptideshop.com